← Open Payments lookup

TAMEY FLEISCHHAUER: Open Payments

NPI 1962152611 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,793 in 84 payments from 19 companies in 2025. Trend: 2023 $241 · 2024 $3,159 · 2025 $2,793

Food & beverage: $2,793
CompanyPaymentsAmount
ABBVIE INC.35$714
UCB, Inc.18$460
Amgen Inc.5$394
Neurocrine BioSciences, Inc.8$288
ARGENX US, INC.1$123
Otsuka America Pharmaceutical, Inc.1$123
Phathom Pharmaceuticals, Inc.1$123
Eisai Inc.2$122
TG Therapeutics, Inc.1$114
Janssen Biotech, Inc.1$100

Products named: QULIPTA, INGREZZA, UPLIZNA, UBRELVY, Briviact, Zilbrysq, VOQUEZNA, REXULTI.

Industry payments across TX — which companies pay providers there.